WallStreetZenWallStreetZen

NASDAQ: BNTX
Biontech Se Stock Ownership - Who owns Biontech Se?

Insider buying vs selling

Have Biontech Se insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BNTX insiders and whales buy or sell their stock.

BNTX Shareholders

What type of owners hold Biontech Se stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baillie Gifford Co3.48%8,276,298$997.46MInstitution
Primecap Management Co2.01%4,789,518$577.23MInstitution
Flossbach Von Storch Ag1.84%4,379,483$527.82MInstitution
Harding Loevner LP1.23%2,926,761$352.73MInstitution
Blackrock Inc0.80%1,895,427$228.44MInstitution
Temasek Holdings Private Ltd0.76%1,807,232$217.81MInstitution
Morgan Stanley0.48%1,147,797$138.33MInstitution
Capital World Investors0.40%955,979$115.21MInstitution
Capital International Investors0.31%743,077$89.56MInstitution
Fmr LLC0.30%701,739$84.57MInstitution

1 of 3

BNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTX17.23%0.00%
ARGX57.27%0.00%
BGNE3.39%34.20%Net SellingNet Selling
MRNA68.21%22.78%Net SellingNet Selling
ALNY81.25%18.75%Net SellingNet Selling

Biontech Se Stock Ownership FAQ

Who owns Biontech Se?

Biontech Se (NASDAQ: BNTX) is owned by 17.23% institutional shareholders, 0.00% Biontech Se insiders, and 82.77% retail investors. Baillie Gifford Co is the largest individual Biontech Se shareholder, owning 8.28M shares representing 3.48% of the company. Baillie Gifford Co's Biontech Se shares are currently valued at $997.46M.

If you're new to stock investing, here's how to buy Biontech Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.